Congenital cytomegalovirus infections. Semin Fetal Neonatal. Med 2007; 12(3):154-59.
Human cytomegalovirus structural proteins. J Gen Virol 1994;75:3287-308.
Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 1986;256(14):1904-08.
Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptual immunity. Ultrasound Obstet Gynecol 2008;31(4):417-20.
Allogeneic transplantation induces expression of Cytomegalovirus immediate-early genes in vivo: A model for reactivation from latency. J Virol 2001;75(10):4814-22.
Spread of human cytomegalovirus (HCMV) after Infection of human hematopoietic progenitor cells: Model of HCMV latency. Blood 1997;90(6):2483-91.
Reactivation of human herpesvirus 6 during pregnancy. J Infect Dis 1999;180(6):2035-38.
Intrauterine transmission of cytomegalovirus to infants of women with preconceptual immunity. NEJM 2001;344(18):1366-71.
Primary versus nonprimary cytomegalovirus infection during pregnancy, Israel. Emerg Infec Dis 2007;13(11): 1791-93.
Longitudinal, serological study of cytomegalovirus infections in nurses and in personnel without patient contact. J Clin Microbiol 1975;2(5):448-52.
Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health. 2005;5:70.
Maternal-fetal cytomegalovirus infection: From diagnosis to therapy. J Matern Fetal Neonatal Med 2009; 22(2):169-74.
Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol 1988;158(5):1189-95.
Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 2006;21(4):399-409.
Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001; 357(9255):513-18.
Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. BJOG 2003;110(6):572-77.
Primary cytomegalovirus infection in pregnancy. JAMA 1986;256(14):1904-08.
The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. MEJM 1992;326(10):663-67.
Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG and IgG avidity assays. J Clin Microbiol. 2009;47(6): 1695-99.
Congenital cytomegalovirus infection in twin pregnancies: Viral load in the amniotic fluid and pregnancy outcome. Pediatrics 2003;112(2):153-57.
Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2000; 183(2): 476-82.
Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection. Obset Gynecol 1999;94(6):909-14.
Sonographic finding in fetal viral infections: A systemic review. Obset Gynecol Surv 2006;61(5):329-36.
Cytomegalovirus-related fetal brain lesions: Comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrsound Obstet Gynecol 2008;32(7):900-05.
Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn 2008;28:753-58.
Pharmacokinetic and pharmacodynamic assessement of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197(6):836-45.
Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birthweight infant. J Perinatol. 2008;28(1): 74-76.
Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transpl Infect Dis. 2005;7(2):71-74.
Absence of teratogencity of oral ganciclovir used during early pregnancy in a liver transplant recipient. Transplantation. 1999;67(5):758-59.
Severe cytomegalovirus hepatitis in a pregnant woman treated with ganciclovir. Scand J Infect Dis. 1998;30:304-05.
Maternal administration of Valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG. 2007;114(9):1113-21.
Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol 2008;111 (2, part 2):524-26.
Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 2008;28(6):512-17.
Passive immunization during pregnancy for congenital cytomegalovirus infection. MEJM 2005;353(13):1350-62.
Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol. 2009 Dec;46 Suppl 4:S54-7 Epub 24 Sep 2009.
Vaccine development to prevent cytomegalovirus disease: A report from the National Vaccine Advisory Committee. Clin Infect Dis 2004;39(2): 233-39.
Vaccine prevention of maternal cytomegalovirus infection. MEJM 2009;360(12):1191-99.
Randomized, double-blind, phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine 2009;28(2):484-93 Epub 24 Oct 2009.
DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates. Vaccine. 2007;25(17):3319-27.